Annual Cash & Cash Equivalents
$77.61 M
+$53.41 M+220.76%
December 31, 2023
Summary
- As of February 8, 2025, CARM annual cash & cash equivalents is $77.61 million, with the most recent change of +$53.41 million (+220.76%) on December 31, 2023.
- During the last 3 years, CARM annual cash & cash equivalents has risen by +$25.82 million (+49.85%).
- CARM annual cash & cash equivalents is now at all-time high.
Performance
CARM Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$26.88 M
-$13.48 M-33.40%
September 30, 2024
Summary
- As of February 8, 2025, CARM quarterly cash and cash equivalents is $26.88 million, with the most recent change of -$13.48 million (-33.40%) on September 30, 2024.
- Over the past year, CARM quarterly cash and cash equivalents has dropped by -$56.25 million (-67.66%).
- CARM quarterly cash and cash equivalents is now -67.66% below its all-time high of $83.13 million, reached on September 30, 2023.
Performance
CARM Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
CARM Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +220.8% | -67.7% |
| 3 y3 years | +49.9% | +11.1% |
| 5 y5 years | +49.9% | +11.1% |
CARM Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +220.8% | -67.7% | +11.1% |
| 5 y | 5-year | at high | +220.8% | -67.7% | +11.1% |
| alltime | all time | at high | +220.8% | -67.7% | +11.1% |
Carisma Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $26.88 M(-33.4%) |
| Jun 2024 | - | $40.36 M(-28.6%) |
| Mar 2024 | - | $56.52 M(-27.2%) |
| Dec 2023 | $77.61 M | $77.61 M(-6.6%) |
| Sep 2023 | - | $83.13 M(+8.9%) |
| Jun 2023 | - | $76.35 M(+21.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $62.78 M(+159.5%) |
| Dec 2022 | $24.19 M(-15.3%) | $24.19 M(-39.1%) |
| Jun 2022 | - | $39.70 M(+39.0%) |
| Dec 2021 | $28.55 M(-44.9%) | - |
| Dec 2021 | - | $28.55 M |
| Dec 2020 | $51.79 M | - |
FAQ
- What is Carisma Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Carisma Therapeutics?
- What is Carisma Therapeutics annual cash & cash equivalents year-on-year change?
- What is Carisma Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Carisma Therapeutics?
- What is Carisma Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Carisma Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of CARM is $77.61 M
What is the all time high annual cash & cash equivalents for Carisma Therapeutics?
Carisma Therapeutics all-time high annual cash & cash equivalents is $77.61 M
What is Carisma Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, CARM annual cash & cash equivalents has changed by +$53.41 M (+220.76%)
What is Carisma Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CARM is $26.88 M
What is the all time high quarterly cash and cash equivalents for Carisma Therapeutics?
Carisma Therapeutics all-time high quarterly cash and cash equivalents is $83.13 M
What is Carisma Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, CARM quarterly cash and cash equivalents has changed by -$56.25 M (-67.66%)